noro2012 - Norovirus and Other Caliciviruses on the Rise

Will be held in Lübeck from 20 to 22 March, 2012

Norovirus is, undoubtedly, on the rise. According to the Robert-Koch-Institute (RKI) in Berlin, the number of norovirus outbreaks has increased by 20% between 2009 and 2010, and the disease is now #1 in Germany among reportable diseases.* In the past few years, new variants of norovirus genotype II.4 have emerged. The number of cases in Germany rose more than 50-fold between 2001 and 2010.** The picture is similar in other countries, both in developed and developing ones. It can therefore be argued that norovirus is an emerging pathogen.

Research on norovirus has made tremendous progress over the past few years. We now understand many details of host-range specificity, receptor binding, the immune response of the host, the replication mechanism of the virus, and epidemiology. And yet, there is no cell culture system, no vaccine and no approved drug available. The debate continues whether or not antivirals would be of use for the treatment of the short-lived disease caused by norovirus infections which, however, is a tremendous burden for health care systems around the world. The situation is aggravated by the recent finding that some patients may shed the virus for weeks after their recovery.

All these aspects will be discussed at "noro2012 - Norovirus and Other Caliciviruses on the Rise", which will take place in the historic town of Lübeck, Germany, between March 20 and 22, 2012. In addition to norovirus, the conference will also discuss the latest results for other caliciviruses, including caliciviruses of animals which represent highly valuable model systems.

For more information about this event, visit the official website at www.noro2012.com

The research leading to these results has received funding from the European Union Seventh Programme (FP7 2007/2013) under grant agreement n°260644-SILVER